Paul Hartmann AG

Research Paul Hartmann AG (PHH2.F) on Bullrun: market cap EUR 690.81M, P/E 6.9, dividend yield 4.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 690.81M; P/E is 6.9; dividend yield is 4.2%.

Peer valuation comparison

Latest P/E is 6.87x versus a Healthcare sector median of 24.6x (72.1% below).

Latest dividend yield is 4.15% versus a Healthcare sector median of 1.84% (125.5% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 2.45BEUR 61.21MEUR 28.40M60.4%17.23EUR 157.08MEUR 351.48MEUR 1.17B
FY2024EUR 2.41BEUR 108.45MEUR 60.06M59.8%30.53EUR 160.91MEUR 290.19MEUR 1.15B
FY2023EUR 2.35BEUR 28.42MEUR 117.68M56.0%8EUR 145.13MEUR 243.31MEUR 1.06B
FY2022EUR 2.31BEUR 36.15M-EUR 119.16M56.7%10.18EUR 107.83MEUR 251.55MEUR 1.08B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-11EUR 690.81M6.94.1%8

Dividend history

Latest trailing dividend snapshot: annual dividend/share 8 EUR, yield 4.2%.

YearDividends/share
FY20258 EUR
FY20248 EUR
FY20238 EUR
FY20228 EUR

About Paul Hartmann AG

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Paul Hartmann AG's market cap?

Paul Hartmann AG's market capitalization is EUR 690.81M.

What is Paul Hartmann AG's P/E ratio?

Paul Hartmann AG's price-to-earnings (P/E) ratio is 6.9.

Does Paul Hartmann AG pay a dividend?

Paul Hartmann AG has a dividend yield of 4.2%.

What does Paul Hartmann AG do?

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management.